Expert Opinion

Patient Selection for Premixed Insulin Formulations in Diabetes Care

Sanjay Kalra, Leszek Czupryniak, Gary Kilov, Roberta Lamptey, Ajay Kumar, A. G. Unnikrishnan, Aissa Boudiba, Mohamed Abid, Zhanay A. Akanov, Ali Latheef, Mustafa Araz, Ralph Audehm, Silver Bahendeka, Naby Balde, Sandeep Chaudhary, Chaicharn Deerochanawong, Olufemi Fasanmade, Hinde Iraqi, Tint Swe Latt, Jean Claude Mbanya & 16 others Joel Rodriguez-Saldana, Ko Seung Hyun, Zafar A. Latif, Maxim Lushchyk, Magdy Megallaa, Mohammed Wali Naseri, Nguyen Quang Bay, Kaushik Ramaiya, Hoosen Randeree, Syed Abbas Raza, Khalid Shaikh, Dina Shrestha, Eugene Sobngwi, Noel Somasundaram, Norlela Sukor, Rima Tan

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Premixed insulins are an important tool for glycemic control in persons with diabetes. Equally important in diabetes care is the selection of the most appropriate insulin regimen for a particular individual at a specific time. Currently, the choice of insulin regimens for initiation or intensification of therapy is a subjective decision. In this article, we share insights, which will help in rational and objective selection of premixed formulations for initiation and intensification of insulin therapy. The glycemic status and its variations in a person help to identify the most appropriate insulin regimen and formulation for him or her. The evolution of objective glucometric indices has enabled better glycemic monitoring of individuals with diabetes. Management of diabetes has evolved from a ‘glucocentric’ approach to a ‘patient-centered’ approach; patient characteristics, needs, and preferences should be evaluated when considering premixed insulin for treatment of diabetes. Funding: Novo Nordisk, India.

Original languageEnglish
Pages (from-to)2185-2199
Number of pages15
JournalDiabetes Therapy
Volume9
Issue number6
DOIs
Publication statusPublished - 1 Dec 2018

Fingerprint

Expert Testimony
Patient Selection
Insulin
Insulins
India
Therapeutics

Keywords

  • BIAsp
  • Coformulation
  • IDegAsp
  • Insulin initiation
  • Insulin intensification
  • LisproMix
  • Patient-centered
  • Premixed
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Kalra, S., Czupryniak, L., Kilov, G., Lamptey, R., Kumar, A., Unnikrishnan, A. G., ... Tan, R. (2018). Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care. Diabetes Therapy, 9(6), 2185-2199. https://doi.org/10.1007/s13300-018-0521-2

Expert Opinion : Patient Selection for Premixed Insulin Formulations in Diabetes Care. / Kalra, Sanjay; Czupryniak, Leszek; Kilov, Gary; Lamptey, Roberta; Kumar, Ajay; Unnikrishnan, A. G.; Boudiba, Aissa; Abid, Mohamed; Akanov, Zhanay A.; Latheef, Ali; Araz, Mustafa; Audehm, Ralph; Bahendeka, Silver; Balde, Naby; Chaudhary, Sandeep; Deerochanawong, Chaicharn; Fasanmade, Olufemi; Iraqi, Hinde; Latt, Tint Swe; Mbanya, Jean Claude; Rodriguez-Saldana, Joel; Hyun, Ko Seung; Latif, Zafar A.; Lushchyk, Maxim; Megallaa, Magdy; Naseri, Mohammed Wali; Bay, Nguyen Quang; Ramaiya, Kaushik; Randeree, Hoosen; Raza, Syed Abbas; Shaikh, Khalid; Shrestha, Dina; Sobngwi, Eugene; Somasundaram, Noel; Sukor, Norlela; Tan, Rima.

In: Diabetes Therapy, Vol. 9, No. 6, 01.12.2018, p. 2185-2199.

Research output: Contribution to journalReview article

Kalra, S, Czupryniak, L, Kilov, G, Lamptey, R, Kumar, A, Unnikrishnan, AG, Boudiba, A, Abid, M, Akanov, ZA, Latheef, A, Araz, M, Audehm, R, Bahendeka, S, Balde, N, Chaudhary, S, Deerochanawong, C, Fasanmade, O, Iraqi, H, Latt, TS, Mbanya, JC, Rodriguez-Saldana, J, Hyun, KS, Latif, ZA, Lushchyk, M, Megallaa, M, Naseri, MW, Bay, NQ, Ramaiya, K, Randeree, H, Raza, SA, Shaikh, K, Shrestha, D, Sobngwi, E, Somasundaram, N, Sukor, N & Tan, R 2018, 'Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care', Diabetes Therapy, vol. 9, no. 6, pp. 2185-2199. https://doi.org/10.1007/s13300-018-0521-2
Kalra S, Czupryniak L, Kilov G, Lamptey R, Kumar A, Unnikrishnan AG et al. Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care. Diabetes Therapy. 2018 Dec 1;9(6):2185-2199. https://doi.org/10.1007/s13300-018-0521-2
Kalra, Sanjay ; Czupryniak, Leszek ; Kilov, Gary ; Lamptey, Roberta ; Kumar, Ajay ; Unnikrishnan, A. G. ; Boudiba, Aissa ; Abid, Mohamed ; Akanov, Zhanay A. ; Latheef, Ali ; Araz, Mustafa ; Audehm, Ralph ; Bahendeka, Silver ; Balde, Naby ; Chaudhary, Sandeep ; Deerochanawong, Chaicharn ; Fasanmade, Olufemi ; Iraqi, Hinde ; Latt, Tint Swe ; Mbanya, Jean Claude ; Rodriguez-Saldana, Joel ; Hyun, Ko Seung ; Latif, Zafar A. ; Lushchyk, Maxim ; Megallaa, Magdy ; Naseri, Mohammed Wali ; Bay, Nguyen Quang ; Ramaiya, Kaushik ; Randeree, Hoosen ; Raza, Syed Abbas ; Shaikh, Khalid ; Shrestha, Dina ; Sobngwi, Eugene ; Somasundaram, Noel ; Sukor, Norlela ; Tan, Rima. / Expert Opinion : Patient Selection for Premixed Insulin Formulations in Diabetes Care. In: Diabetes Therapy. 2018 ; Vol. 9, No. 6. pp. 2185-2199.
@article{8920150e56d64067975512b89c87e2ff,
title = "Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care",
abstract = "Premixed insulins are an important tool for glycemic control in persons with diabetes. Equally important in diabetes care is the selection of the most appropriate insulin regimen for a particular individual at a specific time. Currently, the choice of insulin regimens for initiation or intensification of therapy is a subjective decision. In this article, we share insights, which will help in rational and objective selection of premixed formulations for initiation and intensification of insulin therapy. The glycemic status and its variations in a person help to identify the most appropriate insulin regimen and formulation for him or her. The evolution of objective glucometric indices has enabled better glycemic monitoring of individuals with diabetes. Management of diabetes has evolved from a ‘glucocentric’ approach to a ‘patient-centered’ approach; patient characteristics, needs, and preferences should be evaluated when considering premixed insulin for treatment of diabetes. Funding: Novo Nordisk, India.",
keywords = "BIAsp, Coformulation, IDegAsp, Insulin initiation, Insulin intensification, LisproMix, Patient-centered, Premixed, Type 2 diabetes",
author = "Sanjay Kalra and Leszek Czupryniak and Gary Kilov and Roberta Lamptey and Ajay Kumar and Unnikrishnan, {A. G.} and Aissa Boudiba and Mohamed Abid and Akanov, {Zhanay A.} and Ali Latheef and Mustafa Araz and Ralph Audehm and Silver Bahendeka and Naby Balde and Sandeep Chaudhary and Chaicharn Deerochanawong and Olufemi Fasanmade and Hinde Iraqi and Latt, {Tint Swe} and Mbanya, {Jean Claude} and Joel Rodriguez-Saldana and Hyun, {Ko Seung} and Latif, {Zafar A.} and Maxim Lushchyk and Magdy Megallaa and Naseri, {Mohammed Wali} and Bay, {Nguyen Quang} and Kaushik Ramaiya and Hoosen Randeree and Raza, {Syed Abbas} and Khalid Shaikh and Dina Shrestha and Eugene Sobngwi and Noel Somasundaram and Norlela Sukor and Rima Tan",
year = "2018",
month = "12",
day = "1",
doi = "10.1007/s13300-018-0521-2",
language = "English",
volume = "9",
pages = "2185--2199",
journal = "Diabetes Therapy",
issn = "1869-6953",
publisher = "Springer Publishing Company",
number = "6",

}

TY - JOUR

T1 - Expert Opinion

T2 - Patient Selection for Premixed Insulin Formulations in Diabetes Care

AU - Kalra, Sanjay

AU - Czupryniak, Leszek

AU - Kilov, Gary

AU - Lamptey, Roberta

AU - Kumar, Ajay

AU - Unnikrishnan, A. G.

AU - Boudiba, Aissa

AU - Abid, Mohamed

AU - Akanov, Zhanay A.

AU - Latheef, Ali

AU - Araz, Mustafa

AU - Audehm, Ralph

AU - Bahendeka, Silver

AU - Balde, Naby

AU - Chaudhary, Sandeep

AU - Deerochanawong, Chaicharn

AU - Fasanmade, Olufemi

AU - Iraqi, Hinde

AU - Latt, Tint Swe

AU - Mbanya, Jean Claude

AU - Rodriguez-Saldana, Joel

AU - Hyun, Ko Seung

AU - Latif, Zafar A.

AU - Lushchyk, Maxim

AU - Megallaa, Magdy

AU - Naseri, Mohammed Wali

AU - Bay, Nguyen Quang

AU - Ramaiya, Kaushik

AU - Randeree, Hoosen

AU - Raza, Syed Abbas

AU - Shaikh, Khalid

AU - Shrestha, Dina

AU - Sobngwi, Eugene

AU - Somasundaram, Noel

AU - Sukor, Norlela

AU - Tan, Rima

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Premixed insulins are an important tool for glycemic control in persons with diabetes. Equally important in diabetes care is the selection of the most appropriate insulin regimen for a particular individual at a specific time. Currently, the choice of insulin regimens for initiation or intensification of therapy is a subjective decision. In this article, we share insights, which will help in rational and objective selection of premixed formulations for initiation and intensification of insulin therapy. The glycemic status and its variations in a person help to identify the most appropriate insulin regimen and formulation for him or her. The evolution of objective glucometric indices has enabled better glycemic monitoring of individuals with diabetes. Management of diabetes has evolved from a ‘glucocentric’ approach to a ‘patient-centered’ approach; patient characteristics, needs, and preferences should be evaluated when considering premixed insulin for treatment of diabetes. Funding: Novo Nordisk, India.

AB - Premixed insulins are an important tool for glycemic control in persons with diabetes. Equally important in diabetes care is the selection of the most appropriate insulin regimen for a particular individual at a specific time. Currently, the choice of insulin regimens for initiation or intensification of therapy is a subjective decision. In this article, we share insights, which will help in rational and objective selection of premixed formulations for initiation and intensification of insulin therapy. The glycemic status and its variations in a person help to identify the most appropriate insulin regimen and formulation for him or her. The evolution of objective glucometric indices has enabled better glycemic monitoring of individuals with diabetes. Management of diabetes has evolved from a ‘glucocentric’ approach to a ‘patient-centered’ approach; patient characteristics, needs, and preferences should be evaluated when considering premixed insulin for treatment of diabetes. Funding: Novo Nordisk, India.

KW - BIAsp

KW - Coformulation

KW - IDegAsp

KW - Insulin initiation

KW - Insulin intensification

KW - LisproMix

KW - Patient-centered

KW - Premixed

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85057000981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057000981&partnerID=8YFLogxK

U2 - 10.1007/s13300-018-0521-2

DO - 10.1007/s13300-018-0521-2

M3 - Review article

VL - 9

SP - 2185

EP - 2199

JO - Diabetes Therapy

JF - Diabetes Therapy

SN - 1869-6953

IS - 6

ER -